alexa Erectile Dysfunction: The Problem Hiding Behind Prostate Cancer | Open Access Journals
ISSN: 2161-038X
Reproductive System & Sexual Disorders: Current Research
Like us on:
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Erectile Dysfunction: The Problem Hiding Behind Prostate Cancer

Tarik Emre Sener* and Bahadir Sahin

Department of Urology, School of Medicine, Marmara University, Istanbul, Turkey

*Corresponding Author:
Sener TE
Marmara Universitesi Pendik Egitim ve Arastirma Hastanesi
Uroloji Anabilim Dalı, 4. Kat. Fevzi Cakmak Mah. Muhsin Yazicioglu Cad. Ust Kaynarca
Pendik, Istanbul, Turkiye
Tel: +905337620712
E-mail: [email protected]

Received date: January 12, 2017; Accepted date: January 30, 2017; Published date: February 6, 2017

Citation: Sener TE, Sahin B (2017) Erectile Dysfunction: The Problem Hiding Behind Prostate Cancer. Reprod Syst Sex Disord 6: 201. doi: 10.4172/2161-038X.1000201

Copyright: © 2017 Sener TE, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Reproductive System & Sexual Disorders: Current Research


Letter to Editor

We read with great interest, the article written by Quaresima et al. evaluating the onset of erectile dysfunction (ED) in patients under active surveillance (AS) for low risk prostate cancer. We think that this topic is of huge importance, as ED affects enormously the quality of life in patients who are not under great threat by their primary illness in terms of mortality. Also, when a cancer diagnosis is on the table, many of the complaints that are not directly a cause of mortality are overlooked. Thus, investigating the AS patients for ED carries a significant importance to provide good health care.

Prostate cancer is a major health problem globally with 1,442,460 incident cases in 2013. It is the 8th leading cause of cancer death worldwide as developed countries are affected approximately twice more than developing countries [1]. Life expectancy in men has increase and taken into consideration the higher incidence of prostate cancer in elderly, the overall death from prostate cancer has doubled between 1990 and 2013 according to Dy et al. [1]. However, the mortality rate of untreated low risk prostate cancer with Gleason scores between 5-7 might be as low as 7% [2]. Thus, AS is becoming the way to manage patients with clinically confined, low risk prostate cancer without compromising curative treatment.

A prospective study is what scientific communities need now-a-days and is the appropriate way to investigate AS patients. The purpose of AS is to aim the correct timing for appropriate curative treatment without compromising curative intent, so patient follow-up must be both standardized for a predefined schedule and be individualized for each patient due to different co-morbidities and life-expectancies [3]. One of the largest cohorts with the longest follow-up including 993 patients demonstrated the safety profile of active surveillance as disease-specific survival is 98.1% and 94.3% at 10 and 15 years, respectively [4].

One of the major problems during AS, is the fear of disease progression with general anxiety. According to PRIAS study, this anxiety decreases after 18 months of AS [5]. Considering the cooccurrence of ED with anxiety, ED is rather an early problem of AS and this topic is already covered by Pearce et al. but using different parameters for erectile function assessment [6]. Quaresima et al. preferred the IIEF-5 questionnaire, which provided high sensitivity and specificity and is recommended by the European Association of Urology (EAU) Male Sexual Dysfunction Guidelines [7,8].

High body mass index, diabetes, hypertension and age have been pointed out as contributors to ED onset by the authors which is followed by their comment that a larger cohort is needed to support these findings. However, these factors have already been mentioned as risk factors by Pearle et al. as well as in the EAU Guidelines on Erectile Dysfunction [6,7].

In these contexts, we think the article by Quaresima et al. carries great importance regarding the approach towards patients that will undergo AS. Recognizing those AS patients under risk for ED can change our practice towards ameliorating our diagnostic and therapeutic approaches in terms of erectile function. The potential improvement in ED would decrease anxiety and ensure patients’ wellbeing.


Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

  • International Meeting on Women's Health and Breast Cancer
    Oct 12, 2017, Dubai, UAE
  • International Conference on Gynecology and Obstetrics Pathology
    October 23-24, 2017 Orlando, USA
  • 5th International Conference on HIV/AIDS, STDs and STIs
    Nov 13-14, 2017, Las Vegas, Nevada, USA

Article Usage

  • Total views: 471
  • [From(publication date):
    March-2017 - Sep 22, 2017]
  • Breakdown by view type
  • HTML page views : 408
  • PDF downloads :63

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals


[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version